Western Institutional Review Board (WIRB)
Operates institutional review boards (“IRB”) that must review and approve the handling of ethical issues in research protocols before research involving human subjects can commence. WIRB provides these IRB services for medical and academic research centers, as well as large pharmaceutical, biotech, and medical device companies that play an integral role in the clinical trial process for new drugs and medical devices.
A portfolio company of BV Investment Partners
Has been acquired by Arsenal Capital Partners, New York, NY